Integer (NYSE:ITGR) Insider Kirk Thor Sells 19,773 Shares of Stock

Integer Holdings Corporation (NYSE:ITGR) insider Kirk Thor sold 19,773 shares of the business’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $126.25, for a total value of $2,496,341.25. Following the transaction, the insider owned 18,920 shares in the company, valued at approximately $2,388,650. This represents a 51.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Integer Price Performance

Shares of NYSE ITGR opened at $126.22 on Thursday. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $126.79. The company has a market capitalization of $4.29 billion, a price-to-earnings ratio of 34.49, a PEG ratio of 2.40 and a beta of 0.62. The business has a 50-day moving average of $116.25 and a 200-day moving average of $98.19.

Integer (NYSE:ITGR) last announced its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, beating the consensus estimate of $1.38 by $0.22. The business had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%.The company’s revenue was down 2.6% on a year-over-year basis. During the same period last year, the business posted $1.55 EPS. On average, equities analysts anticipate that Integer Holdings Corporation will post 6.09 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently issued reports on ITGR. Wells Fargo & Company lifted their price target on shares of Integer from $84.00 to $127.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 4th. KeyCorp lowered Integer from an “overweight” rating to a “sector weight” rating in a research report on Monday, August 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a research report on Monday. Raymond James Financial cut Integer from a “moderate buy” rating to a “hold” rating in a research note on Monday, August 3rd. Finally, Citigroup lifted their price target on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. One research analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $109.86.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ITGR. Heartland Advisors Inc. boosted its position in shares of Integer by 506.8% during the fourth quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock worth $19,036,000 after buying an additional 202,715 shares during the period. WINTON GROUP Ltd bought a new position in Integer in the 4th quarter worth approximately $4,836,000. William Blair Investment Management LLC increased its position in Integer by 70.1% in the 4th quarter. William Blair Investment Management LLC now owns 468,377 shares of the medical equipment provider’s stock valued at $36,735,000 after acquiring an additional 192,956 shares during the period. Assenagon Asset Management S.A. acquired a new stake in Integer in the 2nd quarter valued at approximately $746,000. Finally, First National Bank of Omaha bought a new stake in Integer during the 2nd quarter valued at $1,725,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.

Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.